Technical Analysis for RCEL - Avita Medical Limited

Grade Last Price % Change Price Change
C 10.30 1.98% 0.20
RCEL closed up 1.98 percent on Friday, November 1, 2024, on 82 percent of normal volume. It was able to find support at its 50 day moving average.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Resistance Bearish 1.98%
50 DMA Support Bullish 1.98%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.98%
Bollinger Band Squeeze Range Contraction 1.98%
20 DMA Resistance Bearish -0.87%
Bollinger Band Squeeze Range Contraction -0.87%

   Recent Intraday Alerts

Alert Time
Non-ADX 1,2,3,4 Pullback Entry about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
Up 3% about 20 hours ago
Rose Above 20 DMA about 23 hours ago
Rose Above 10 DMA about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avita Medical Limited Description

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Rare Diseases Clinical Research Dermatology Wound Suspension Regenerative Medicine Platform Technology Burns Genodermatoses Aesthetics Epidermolysis Bullosa Skin Chronic Wound Chronic Wounds Treatment Solutions

Is RCEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.93
52 Week Low 7.51
Average Volume 87,538
200-Day Moving Average 11.37
50-Day Moving Average 10.12
20-Day Moving Average 10.35
10-Day Moving Average 10.35
Average True Range 0.46
RSI (14) 49.75
ADX 16.67
+DI 16.38
-DI 13.31
Chandelier Exit (Long, 3 ATRs) 9.67
Chandelier Exit (Short, 3 ATRs) 11.11
Upper Bollinger Bands 10.76
Lower Bollinger Band 9.94
Percent B (%b) 0.44
BandWidth 7.95
MACD Line 0.02
MACD Signal Line 0.07
MACD Histogram -0.0489
Fundamentals Value
Market Cap 263.17 Million
Num Shares 25.6 Million
EPS -1.34
Price-to-Earnings (P/E) Ratio -7.69
Price-to-Sales 10.13
Price-to-Book 7.30
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.90
Resistance 3 (R3) 10.90 10.70 10.80
Resistance 2 (R2) 10.70 10.55 10.70 10.77
Resistance 1 (R1) 10.50 10.45 10.60 10.50 10.73
Pivot Point 10.30 10.30 10.35 10.30 10.30
Support 1 (S1) 10.10 10.15 10.20 10.10 9.87
Support 2 (S2) 9.90 10.05 9.90 9.83
Support 3 (S3) 9.70 9.90 9.80
Support 4 (S4) 9.70